Informations:
Erreur:
ID
22086
Description
Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00280878
Lien
https://clinicaltrials.gov/show/NCT00280878
Mots-clés
Versions (1)
- 19/05/2017 19/05/2017 -
Téléchargé le
19 mai 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Non-Hodgkin's Lymphoma (CD20+) NCT00280878
Eligibility Non-Hodgkin's Lymphoma (CD20+) NCT00280878
- StudyEvent: Eligibility
Similar models
Eligibility Non-Hodgkin's Lymphoma (CD20+) NCT00280878
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Age
Item
age >18 years
boolean
C0001779 (UMLS CUI [1])
Non-Hodgkin's lymphoma recurrent CD20 antigen positive | Non-Hodgkin's lymphoma refractory Primary CD20 antigen positive
Item
relapsed or primary refractory cd20+ nhl
boolean
C0854866 (UMLS CUI [1,1])
C3888518 (UMLS CUI [1,2])
C0854867 (UMLS CUI [2,1])
C0205225 (UMLS CUI [2,2])
C3888518 (UMLS CUI [2,3])
C3888518 (UMLS CUI [1,2])
C0854867 (UMLS CUI [2,1])
C0205225 (UMLS CUI [2,2])
C3888518 (UMLS CUI [2,3])
ECOG performance status
Item
ecog 0 - 2
boolean
C1520224 (UMLS CUI [1])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Salvage Therapy Quantity | Intent Transplantation
Item
intention to proceed with any form of transplant therapy following fewer than 2 cycles of protocol salvage therapy.
boolean
C0085405 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1283828 (UMLS CUI [2,1])
C0040732 (UMLS CUI [2,2])
C1265611 (UMLS CUI [1,2])
C1283828 (UMLS CUI [2,1])
C0040732 (UMLS CUI [2,2])
Serum total bilirubin measurement | Bilirubin Secondary to Lymphoma
Item
bilirubin > 50µmol/litre unless secondary to lymphoma
boolean
C1278039 (UMLS CUI [1])
C0005437 (UMLS CUI [2,1])
C0175668 (UMLS CUI [2,2])
C0024299 (UMLS CUI [2,3])
C0005437 (UMLS CUI [2,1])
C0175668 (UMLS CUI [2,2])
C0024299 (UMLS CUI [2,3])
Serum creatinine raised | Serum creatinine raised Secondary to Lymphoma
Item
creatinine > 2 x upper limit of normal unless secondary to lymphoma
boolean
C0700225 (UMLS CUI [1])
C0700225 (UMLS CUI [2,1])
C0175668 (UMLS CUI [2,2])
C0024299 (UMLS CUI [2,3])
C0700225 (UMLS CUI [2,1])
C0175668 (UMLS CUI [2,2])
C0024299 (UMLS CUI [2,3])
Absolute neutrophil count | Absolute neutrophil count Secondary to Lymphoma | Platelet Count measurement | Blood Platelets Secondary to Lymphoma
Item
absolute neutrophil count <0.5 x 109/litre and / or platelets < 50 x 109/litre unless secondary to lymphoma
boolean
C0948762 (UMLS CUI [1])
C0948762 (UMLS CUI [2,1])
C0175668 (UMLS CUI [2,2])
C0024299 (UMLS CUI [2,3])
C0032181 (UMLS CUI [3])
C0005821 (UMLS CUI [4,1])
C0175668 (UMLS CUI [4,2])
C0024299 (UMLS CUI [4,3])
C0948762 (UMLS CUI [2,1])
C0175668 (UMLS CUI [2,2])
C0024299 (UMLS CUI [2,3])
C0032181 (UMLS CUI [3])
C0005821 (UMLS CUI [4,1])
C0175668 (UMLS CUI [4,2])
C0024299 (UMLS CUI [4,3])
Transplantation, Autologous | Transplantation, Homologous | Recurrent disease
Item
relapse within 6 months of a prior transplant procedure (autologous or allogeneic).
boolean
C0040736 (UMLS CUI [1])
C0040739 (UMLS CUI [2])
C0277556 (UMLS CUI [3])
C0040739 (UMLS CUI [2])
C0277556 (UMLS CUI [3])
Hypersensitivity Pharmaceutical Preparations Escherichia coli Derived
Item
known sensitivity to e coli derived preparations
boolean
C0020517 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0014834 (UMLS CUI [1,3])
C1441547 (UMLS CUI [1,4])
C0013227 (UMLS CUI [1,2])
C0014834 (UMLS CUI [1,3])
C1441547 (UMLS CUI [1,4])